Global In-Vitro Diagnostic Reagents (Antibodies, Oligonucleotide, Nucleic Acid Probe) Markets, 2020-2027

DUBLIN, April 14, 2021 /PRNewswire/ -- The "In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Oligonucleotide, Nucleic Acid Probe), Technology (Immunoassay, Hematology, Microbiology), Use (Research, Analyte Specific Reagent), End User (IVD Manufacturer, Clinical Laboratory) - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The IVD reagents market is expected to grow at a CAGR of 7% from 2020 to 2027 to reach $77.6 billion by 2027.

The growth in the IVD reagents market is mainly attributed to the factors such as increasing global prevalence of acute and chronic infectious diseases coupled with rising geriatric population, increasing adoption of flow cytometry techniques in research and academia, increase in funding for research activities, and rising proteomics and genomics research studies. Moreover, the growing demand for protein therapeutics and personalized medicines and emerging economies offer significant growth opportunities for the players operating in this market.

The global IVD reagents market study presents historical market data in terms of values (2018 and 2019), estimated current data (2020), and forecasts for 2027- by type (oligonucleotide, antibodies, nucleic acid probe), technology (immunoassay, hematology, microbiology), use (research, analyte specific reagent), end user (IVD manufacturer, clinical laboratory), and geography. The study also evaluates industry competitors and analyzes the market at regional level.

Based on technology, the immunoassay/immunochemistry segment is estimated to dominate the overall IVD reagents market in 2020. The large share of this segment is mainly attributed to the increasing use of immunoassays in infectious disease testing, development of novel tests, and rising demand for immunoassay-based tests. Further, the outbreak of coronavirus (COVID-19) disease since December 2019 is expected to accelerate the growth of this segment owing to the national emergency declared and requirement of various reagents for the kits and assay preparation.

Based on type, the antibodies segment is estimated to hold the largest share of the overall IVD reagents market in 2020. However, the oligonucleotides segment is expected to grow at the fastest CAGR during the forecast period. The fast growth of this segment is mainly attributed to the factors such as advancements in the field of genomics research, growing adoption of custom oligonucleotides, and rising strategic developments such as agreements and collaborations to expand oligonucleotides market.

Based on end user, the IVD manufacturers segment is estimated to command the largest share of the overall IVD reagents market in 2020. The factors such as rising number of research activities for the development of innovative IVDs, growing public and private funds, and rising demand for advanced disease diagnostics are expected to drive the growth of the IVD reagents market for IVD manufacturing during the forecast period.

Moreover, the recent outbreak of COVID-19 is also expected to support the growth of the IVD reagents market for this segment. However, the clinical laboratories segment is expected to register the highest growth during the forecast period, due to the rising number of accredited clinical laboratories; growing collaborations, partnerships, and other strategies undertaken by the key players; and outbreak of COVID-19.

Market Insights

Drivers

• Increasing Prevalence of Acute and Chronic Infectious Diseases
• Increasing Funding for Research Activities
• Increasing Adoption of Flow Cytometry Techniques
• Rising Proteomics and Genomics Research Studies

Restraints

• Stringent Regulations Antigen-Specific Reagents

Opportunities

• Growing Demand for Protein Therapeutics and Personalized Medicines
• Emerging Economies

Challenges

• High Cost & Unfavorable Reimbursement Scenario

Scope of the Report:

IVD Reagents Market, by Technology

• Immunoassay/Immunochemistry
• Enzyme-Linked Immunosorbent Assays (Elisa)
• Western Blotting
• Immunofluorescence
• Immunohistochemistry
• Functional Assays
• Immunoprecipitation
• Other Technologies
• Biochemistry/Clinical Chemistry
• Molecular Diagnostics
• Microbiology
• Hematology
• Coagulation/Hemostatis
• Urinalysis
• Other Technologies
• (Other Technologies comprises of hybridization and loop-mediated isothermal amplification among others)

IVD Reagents Market, by Type

• Antibodies
• Antibodies Market, By Type
• Monoclonal
• Polyclonal
• Antibodies Market, By Target
• CD
• TCR
• EGFR
• Other Targets
• Oligonucleotides
• Nucleic Acid Probes
• Purified Proteins or Peptides
• Other Reagents
• (Other reagents include Blocking Agents, Detergents, Surfactants, Wetting Agents, Buffers, Stabilizers, Purified Water, Dyes, Standards & Controls, Enzymes, Cell Culture Reagents, and Anti-coagulants)

IVD Reagents Market, by Use

• Research Use Only
• Analyte Specific Reagents
• Clinical Use

IVD Reagents Market, by End User

• IVD Manufacturers
• Reference Laboratories
• Academic and Research Institutes
• Hospital Laboratories

IVD Reagents Market, by Geography

• North America
• U.S.
• Canada
• Europe
• Germany
• Italy
• France
• U.K.
• Spain
• Rest of Europe (RoE)
• Asia-Pacific (APAC)
• Japan
• China
• India
• Rest of Asia Pacific (RoAPAC)
• Latin America
• Middle East & Africa

Company Profiles

• Abcam plc (U.K.)
• Agilent Technologies Inc. (U.S.)
• Beckman Coulter Inc. (U.S.)
• Becton
• Bio-Rad Laboratories Inc. (U.S.)
• Bio-Synthesis Inc. (U.S.)
• Bio-Techne Corporation (U.S.)
• BioLegend Inc. (U.S.)
• Bioline (U.K.)
• DIACLONE SAS (France)
• Dickinson and Company (U.S.)
• Hologic Inc. (U.S.)
• InBios International Inc. (U.S.)
• LGC Biosearch Technologies (U.K.)
• LakePharma Inc. (U.S.)
• Merck KGaA (Germany)
• RayBiotech Inc. (U.S.)
• SDIX LLC (U.S.)
• Sino Biological Inc. (China).
• The Binding Site Group Ltd.(U.K.)
• Thermo Fisher Scientific (U.S.)

For more information about this report visit https://www.researchandmarkets.com/r/ly7905

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com